Lycia Therapeutics raised $106M in a Series C financing led by Venrock Healthcare Capital Partners for the development of lysosomal targeting chimeras (lytacs) to treat autoimmune and inflammatory diseases.
Amount Raised
$106 Million
Round Type
Series C
South San FranciscoBiotechnologyInvestors
Description
Lycia Therapeutics, a startup based in South San Francisco, raised $106 million in a Series C financing led by Venrock Healthcare Capital Partners. The funding will advance the research and development of lysosomal targeting chimeras (lytacs) aimed at treating autoimmune and inflammatory diseases.
Quick answer
Lycia Therapeutics, Inc. raised $106 Million in a Series C round, dated May 13, 2024. Investors: Franklin Templeton, Marshall Wace, Janus Henderson Investors and Venrock Healthcare Capital Partners. Lycia Therapeutics, Inc. is based in South San Francisco, California, United States.
- How much did Lycia Therapeutics, Inc. raise?
- Lycia Therapeutics, Inc. raised $106 Million in a Series C round on May 13, 2024.
- Who invested in Lycia Therapeutics, Inc?
- Franklin Templeton, Marshall Wace, Janus Henderson Investors and Venrock Healthcare Capital Partners are named as investors in this round.
- What does Lycia Therapeutics, Inc. do?
- Lycia is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting chimera) protein degraders that..
- Where is Lycia Therapeutics, Inc. based and how big is it?
- Lycia Therapeutics, Inc. is based in South San Francisco, California, United States. Fundz records about 37 employees.
- Who are the decision-makers at Lycia Therapeutics, Inc?
- Fundz holds 1 contact at Lycia Therapeutics, Inc., including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Lycia Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Climb Bio, Inc. raised $42M on June 27, 2024.
- EPICYPHER raised $3.3M on June 27, 2024.
- Holoclara raised $16M (Series A) on June 27, 2024.
- Climb Bio, Inc. raised $120M on June 27, 2024.
- Vertus Energy raised $9.5M (Seed) on June 27, 2024.
- CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
Who to call at Lycia Therapeutics, Inc., and when
A new round usually means Lycia Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lycia Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lycia Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lycia Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lycia Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lycia Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.